Brain tumor surgery is particularly difficult because neurosurgeons often face difficult trade-offs: remove more tumor and risk nerve damage, or preserve function and leave more tumor behind. The corpus callosum is the major deep connecting bridge between the two hemispheres of the brain and is located near important functional pathways, making surgical removal of tumors affecting this region even more difficult. IDH-mutated low-grade corpus callosal glioma (ccLGG) is a rare group of tumors that arise from glial cells that support nerve cells in this vitally important region. Traditional surgery to remove ccLGG is guided by ‘neuronavigation’, a technique used to map the 3D location of the tumor within the brain using MRI images taken before surgery. However, its position may change slightly during surgery, risking damage to adjacent normal structures and incomplete removal of the tumor.
A new technology called “intraoperative MRI” (iMRI) takes MRI images on the operating table to help surgeons see if any tumor remains and remove further if necessary. Another method, called neuromonitoring, continuously monitors brain and nerve function during surgery and alerts surgeons when they get too close to critical areas that control things like movement, language, and sensation. Chinese Neurosurgical Journal On May 1, 2026, researchers at the People’s Liberation Army General Hospital in China directly compared traditional neuronavigation-guided surgery with multidisciplinary surgery that combines neuronavigation, intraoperative MRI, and neuromonitoring. ”Few studies have investigated the combined effects of these techniques, especially in this rare tumor population.” said senior author Dr. Jiangning Jiang.
Researchers examined medical records of patients diagnosed with IDH variant ccLGG who underwent surgery at the hospital between 2014 and 2022. Sixty-four patients who underwent surgery with multidisciplinary techniques were compared with 34 patients who underwent conventional surgery. Comparison criteria were the amount of tumor removed, damage to brain or neurological function, quality of life, time to further tumor progression, and survival after surgery. ”We wanted to find out whether using several advanced surgical techniques together in a “multimodal” approach allows neurosurgeons to safely remove more tumors, which factors help extend patients’ lives, and which factors prevent tumor recurrence.” explains lead author Dr. Meng Cui.
They found that complete tumor removal is much more common when using advanced techniques, and the chances of complete tumor removal are almost twice as high compared to traditional surgery. In addition, improvements in tumor removal through multidisciplinary surgery meant that patients lived approximately 30 months longer after treatment before their tumors recurred or worsened, and they lived more than 3 years longer. Therefore, it turns out that the use of multimodal techniques has the potential to improve the quality of life of patients without causing extra disability. ”This study suggests that multidisciplinary surgical guidance should be considered when resources permit for complex gliomas involving important brain structures.” says Dr. Zhang.
The effect was even greater when combined with chemotherapy after surgery. In particular, patients who received more cycles of chemotherapy with a drug called temozolomide tended to survive longer. Smaller tumors with less spread, tumors that involved only the anterior part of the corpus callosum (called butterfly tumors), and tumors that did not spread to both sides (called butterfly tumors) were also associated with better outcomes. At three months of age, patients also had higher KPS scores, a measure of how well they perform activities of daily living, and those with MGMT methylation, a biological marker associated with improved response to treatment.
Extensive investment in advanced medical technologies, such as iMRI and neuromonitoring, can help doctors safely remove difficult tumors like IDH-mutant ccLGG, providing patients with more complete tumor resection, longer survival, and longer tumor-free periods.
sauce:
Chinese Neurosurgical Journal
Reference magazines:
Choi, M. Others. (2026) Multimodal technique, retrospective study and prognostic analysis for maximally safe resection of IDH mutant low-grade gliomas involving the corpus callosum. Chinese Neurosurgical Journal. DOI: 10.1186/s41016-026-00432-y. https://link.springer.com/article/10.1186/s41016-026-00432-y
